Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Waitaki Biosciences, a subsidiary of PharmaZen Limited, is a New Zealand-based developer and manufacturer of high-value natural nutritional ingredients for the global nutraceutical and pharmaceutical industries. The company specializes in the extraction of bioactive compounds from New Zealand's primary industries, including bovine bone, cartilage, and marine sources such as greenshell mussels. Their product portfolio features specialty proteins, lipids, and complex carbohydrates designed to support joint health, bone density, and immune function. Waitaki Canada serves as the primary distribution and sales hub for the North American market, facilitating the supply of flagship ingredients like MCH-Cal and StimuCal. The company utilizes advanced processing technologies, including freeze-drying and solvent extraction, to ensure the bioactivity and purity of its natural products. With a focus on sustainability and clinical evidence, Waitaki provides essential raw materials for dietary supplements, personal care products, and functional foods.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Waitaki Canada.